Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 8 years, Springer Nature AG KGaA's highest 3-Year average EPS without NRI Growth Rate was 477.90% per year. The lowest was 477.90% per year. And the median was 477.90% per year.
Springer Nature AG KGaA (OTCPK:SPGNY) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Springer Nature AG KGaA EPS (Diluted) Related Terms
Springer Nature AG KGaA EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Publishing subindustry, Springer Nature AG KGaA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Springer Nature AG KGaA PE Ratio vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Springer Nature AG KGaA's PE Ratio distribution charts can be found below:
* The bar in red indicates where Springer Nature AG KGaA's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Springer Nature AG KGaA's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Springer Nature AG KGaA (SPGNY) has a EPS (Diluted) of $2.10 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Springer Nature AG KGaA and its competitors.
Is Springer Nature AG KGaA's EPS (Diluted) too high?
Springer Nature AG KGaA's current EPS (Diluted) is $2.10. Overall, Springer Nature AG KGaA has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Springer Nature AG KGaA's EPS (Diluted) compare to NYT and WLY?
Springer Nature AG KGaA's EPS (Diluted) of $2.10 can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Media - Diversified company?
A good EPS (Diluted) depends on the Media - Diversified industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Springer Nature AG KGaA and its competitors. Springer Nature AG KGaA's current EPS (Diluted) is $2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Springer Nature AG KGaA stock overvalued right now?
Springer Nature AG KGaA (SPGNY) has a current EPS (Diluted) of $2.10. The current EPS (Diluted) is $2.10. Springer Nature AG KGaA's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Springer Nature AG KGaA (SPGNY), the current EPS (Diluted) is $2.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Springer Nature AG & Co KGaA is a research, educational, and professional publisher providing content to communities through a range of platforms, products, and services. It offers journals, books, platforms, databases & and solutions. The company includes three Segments: Research, Education, and Health. The company operates in the Americas, APAC, Germany, and Other EMEA regions. The majority of revenue is generated from the research segment in America.
41GF Score
Get the complete analysis for SPGNY
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPGNY has been successfully added to your 
